Predictmedix Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
74040N106
SEDOL
N/A
CIK
0001868079
www.predictmedix.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG00R4SPLM6
PMEDF
Predictmedix Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Devices
AI
PROFILER
NAME
Predictmedix Inc.
ISIN
CA74040N1069
TICKER
PMEDF
MIC
XOTC
REUTERS
PMEDF.PK
BLOOMBERG
PMEDF US
F&G: 75
1,36918 USDCAD · 118.562,61 BTC · 17,28 Vola-Index · 22.773,43 Tech100
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mi., 02.07.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening — with India identified as the initial launchpad for this transformative initiative. Lever...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Di., 20.05.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leader in AI-powered health and safety technology, is proud to announce a high-impact strategic alliance with Pacific Mechatronics Pvt. Ltd., a premier systems integrator with deep-rooted access to Asia-Pacific’s defence, aerospace, and national security ...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Do., 08.05.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-driven health and safety solutions, is proud to announce its participation as one of four profiled companies in an exclusive European investor roadshow spanning Budapest (Hungary), Zagreb (Croatia), and Belgrade (Serbia) from May 17...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Fr., 11.04.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-driven health and safety solutions, welcomes the U.S. Food and Drug Administration’s (FDA) groundbreaking move to phase out mandatory animal testing in drug development. As the pharmaceutical and biotech industries pivot toward more...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Mo., 07.04.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-driven health and safety solutions, proudly announces a significant milestone: its Smart Health AI Stations have successfully completed over 500,000 individual scans. This achievement highlights the scalability, precision, and real-...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Di., 01.04.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the third and the final tranche of its non-brokered private placement, raising total gross proceeds of $100,000 CAD. Notably, $90,000 of the tranch...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Mi., 19.03.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the second tranche of its non-brokered private placement, raising total gross proceeds of $405,500. Notably, this tranche saw strong participation ...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Fr., 28.02.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), an innovative provider of AI-powered health screening solutions, is pleased to announce that it is launching its enhanced Smart Health AI Stations across the United States, positioning itself to capitalize on the rapidly expanding population health manageme...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Sa., 22.02.2025       Predictmedix
CA74040N1069

Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) ("Predictmedix" or the "Company"), a leading provider of AI-powered health screening solutions, is pleased to announce the successful closing of the first tranche of its non-brokered private placement. The Company issued 16,000,000 units ("Units") at an issue price of $0.02 per Unit, raising...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
Mi., 12.02.2025       Predictmedix
CA74040N1069

Predictmedix AI (CSE: PMED | OTC: PMEDF | FRA: 3QP) (the “Company” or “Predictmedix”) is repositioning itself as an emerging leader in AI-powered health management technologies, with a strategic shift toward solutions that go beyond traditional healthcare. The Company’s approach emphasizes workplace safety, workforce readiness, and public sector h...
weiterlesen
Predictmedix
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S